Details of the Drug

General Information of Drug (ID: DMDEFXN)

• Drug Name: IPL-512602
• Synonyms: BLX-LSAID; IPL-576 series; OX-LSAID; Lead LSAID (asthma), Biolipox; Lead LSAID (asthma), Orexo; Lead LSAID (asthma), Inflazyme/Aventis; Lead LSAID (asthma), Inflazyme/sanofi-aventis

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Phase 2	[1]

• Cross-matching ID: TTD ID: D0I8CK

References

• [1] ClinicalTrials.gov (NCT00330070) Control of Asthma Patients Symptomatic on Inhaled Corticosteroids. U.S. National Institutes of Health.